MedTrace Logo

Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris

NCT04596748 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-11-24

No results posted yet for this study

Summary

The purpose of this study is to determine how probiotics affect sebum production and gut health in those with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DIETARY_SUPPLEMENT

Probiotic

Bacillus Subtilis, Bacillus Clausii, Bacillus Coagulans, Bacillus Indicus HU36, MCC 102

DIETARY_SUPPLEMENT

Placebo

Placebo caps

Sponsors & Collaborators

  • Microbiome labs

    collaborator UNKNOWN

  • Integrative Skin Science and Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04596748 on ClinicalTrials.gov